Affinity Therapeutics

Affinity Therapeutics was a private, research-driven biotechnology company focused on controlled-release drug delivery technologies for medical applications. The company described a tunable platform designed to customize and calibrate therapeutic release over days to months, with potential use across regenerative medicine, oncology, and advanced wound therapy. Publicly available sources characterize the company as Ohio-based and permanently closed. There is no clear evidence of an active clinical-stage therapeutic pipeline, suggesting the business centered more on platform and formulation technology than on named late-stage drug assets.